Dr. Daniel Sand, MD

Dr. Sand practices at Huntington Ambulatory Surgery Center - HOPD in Pasadena, California.

Dr. Sand's NPI, 1255650453, was assigned on May 27, 2010. Dr. Sand graduated from Cleveland Medical College, Homeopathic in 2010. Dr. Sand holds California license A119975.

Dr. Sand's primary practice is Huntington Ambulatory Surgery Center - HOPD, at 625 S Fair Oaks Ave, Pasadena, CA 91105.

Dr. Sand's primary practice is Huntington Ambulatory Surgery Center - HOPD in Pasadena, California. Dr. Sand is also affiliated with Ronald Reagan UCLA Medical Center. Dmand AI also links Dr. Sand to 2 more group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Sand practices, 4 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Sand's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Sand is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Sand's licenses on file in 2 states: California and Michigan.

Dmand AI lists dry eye among the conditions Dr. Sand treats.

CMS data shows 173 Medicare services from Dr. Sand across 8 procedure codes in 2024, for 111 Medicare patients. Medicare paid $15,489 for them. Every service was in an office.

CMS counts 111 Medicare patients who saw Dr. Sand in 2024. The largest group is 65 to 74, with 59 patients. 70% of them have high cholesterol, and 68% have high blood pressure. 32% are also on Medicaid. Their average risk score is 1.44, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Sand's median patient age at 63, with 59% women.

In 2024, Dr. Sand wrote 136 Medicare Part D claims for 51 patients. 90% of them were for generic drugs. CMS names the drug for 113 of them, across 4 drugs with 11 or more claims each, at $1,387 in total drug cost. In 2023, CMS named 91 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 86 out of 100 for Dr. Sand for performance year 2024, reported as part of a group. Dr. Sand accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 11 procedures of cataract surgery by Dr. Sand, more than 32% of the clinicians it reports for that procedure.

Dmand AI links 43 papers to Dr. Sand, published from 2005 to 2016. 2012 was the busiest year, with 5. The most frequent topics are Skin Neoplasms, MicroRNAs and Gene Expression Regulation, Neoplastic. Dr. Sand has published most often in Dermatol Surg. Dr. Sand's most frequent co-authors are Klaus Dietrich Hoffmann, MD and Thomas Lowell Meyer, MD.

CMS Open Payments shows 10 general payments to Dr. Sand from 5 drug and device companies from 2017 to 2023. Food and beverage make up the largest share, 96% of the total. Carl Zeiss Meditec, Inc. paid the most, $215.

Dr. Sand graduated from Cleveland Medical College, Homeopathic in 2010.

Dr. Sand is in network with 15 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.